Literature DB >> 8152797

Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.

R P Huang1, T Darland, D Okamura, D Mercola, E D Adamson.   

Abstract

The transcription factor Egr-1, stimulates the activity of a number of genes and inhibits other genes, by binding to the sequence GCGGGGGCG in 5' enhancer regions. However, the functions of Egr-1 are obscure in spite of its rather ubiquitous expression. Egr-1 may play a role in proliferation in mitogen-stimulated cells but its expression is also correlated with the differentiated state in teratocarcinoma cells. The constitutive expression of Egr-1 appears to have little effect on the growth rate of normal immortalized cell-lines. We show that in NIH3T3 cells that are conditionally transformed by the expression of v-six, the presence of Egr-1 is inhibitory to the production of transformed colonies (foci) and to growth in soft agar. In addition, the first appearance of tumors in nu/nu mice is delayed in tumorigenicity tests with cells that over-express Egr-1 and tumor growth is suppressed compared to control cells. We used a series of fragments of Egr-1 cloned into expression vectors to show that not only full length, but also truncated Egr-1 fragments inhibit colony formation. Using deletion mutants, we observed that this inhibitory activity is dependent on the presence of the DNA-binding 'zinc-finger' region. Wilm's tumor protein, WT1, (known to be a tumor suppressor gene) that exhibits the same DNA binding activity is also inhibitory. In contrast, colony formation is stimulated by an Egr-1 antisense RNA-expressing plasmid, since colonies grow rapidly and the colony-forming frequency is higher than in the presence of v-sis alone. We conclude that proteins containing the Egr-1 'zinc-finger' domain can bind to the regulatory regions of one or more genes that are required for the transformation of fibroblasts by v-sis thus inhibiting transformation. One function for Egr-1 implied by these results is the restraint of transformed growth in mitogen-stimulated cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152797

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1.

Authors:  C Liu; E Adamson; D Mercola
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

2.  Building zinc fingers by selection: toward a therapeutic application.

Authors:  H Wu; W P Yang; C F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

3.  Molecular remodelling in hypertrophied hearts from polyomavirus large T-antigen transgenic mice.

Authors:  E L Holder; A E Al Moustafa; L E Chalifour
Journal:  Mol Cell Biochem       Date:  1995-11-22       Impact factor: 3.396

4.  Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines.

Authors:  Miao-Wang Hao; Ying-Rui Liang; Yan-Fang Liu; Li Liu; Ming-Yao Wu; Huan-Xing Yang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

5.  Iron deficiency upregulates Egr1 expression.

Authors:  Seung-Min Lee; Sun Bok Lee; Ron Prywes; Christopher D Vulpe
Journal:  Genes Nutr       Date:  2015-05-19       Impact factor: 5.523

6.  Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway.

Authors:  R A Gjerset; H Fakhrai; D L Shawler; S Turla; O Dorigo; A Grover-Bardwick; D Mercola; S F Wen; H Collins; H Lin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

7.  Transdifferentiation-inducing HCCR-1 oncogene.

Authors:  Seon-Ah Ha; Hyun K Kim; JinAh Yoo; SangHee Kim; Seung M Shin; Youn S Lee; Soo Y Hur; Yong W Kim; Tae E Kim; Yeun J Chung; Shin S Jeun; Dong W Kim; Yong G Park; Jin Kim; Soon Y Shin; Young H Lee; Jin W Kim
Journal:  BMC Cell Biol       Date:  2010-06-30       Impact factor: 4.241

8.  Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis.

Authors:  Xuefei Cao; Carmen Plasencia; Atsuko Kanzaki; Austin Yang; Terrence R Burke; Nouri Neamati
Journal:  Curr Cancer Drug Targets       Date:  2009-03       Impact factor: 3.428

9.  Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases.

Authors:  Min Fang; Sue Ann Wee; Karyn Ronski; Hongran Fan; Shiying Tao; Qun Lin
Journal:  Genomic Med       Date:  2007-07-25

10.  Decreased EGR3 expression is related to poor prognosis in patients with gastric cancer.

Authors:  Fei Liao; Meng-Yao Ji; Lei Shen; Shi Qiu; Xu-feng Guo; Wei-guo Dong
Journal:  J Mol Histol       Date:  2013-03-05       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.